Jurgėnų biokuras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 99,608 | 85,084 | 85,791 | 231,830 | 472,989 | 356,322 | 263,418 | 234,142 |
| Profit before tax | 1,140 | 1,218 | 645 | 1,498 | 2,010 | 720 | 324 | 1,058 |
| Net profit | 1,083 | 1,157 | 613 | 1,423 | 1,708 | 612 | 305 | 996 |
| Equity | 85,384 | 86,541 | 87,154 | 88,577 | 90,285 | 90,897 | 91,202 | 92,198 |
| Liabilities | 15,139 | 25,839 | 14,473 | 69,578 | 112,645 | 105,210 | 115,878 | 111,163 |
| Non-current assets | 98,145 | 77,828 | 58,835 | 80,067 | 186,084 | 149,633 | 114,475 | 115,621 |
| Current assets | 37,242 | 58,265 | 55,394 | 99,300 | 92,507 | 105,104 | 133,711 | 146,203 |
| Total assets | 135,387 | 136,093 | 114,229 | 179,367 | 278,591 | 254,737 | 248,186 | 261,824 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 346 | 14,261 |
| Social insurance contributions | - | - | - | - | - | 10,079 | 5,924 | 4,922 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +153.9% | -14.6% | +0.8% | +170.2% | +104.0% | -24.7% | -26.1% | -11.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.8% | 0.9% | 0.5% | 0.8% | 0.6% | 0.2% | 0.1% | 0.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.3% | 1.3% | 0.7% | 1.6% | 1.9% | 0.7% | 0.3% | 1.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.1% | 1.4% | 0.7% | 0.6% | 0.4% | 0.2% | 0.1% | 0.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.1% | 1.4% | 0.8% | 0.6% | 0.4% | 0.2% | 0.1% | 0.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.3 | 0.2 | 0.8 | 1.2 | 1.2 | 1.3 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 17,323 | 13,986 | 12,710 | 33,517 | 39,416 | 36,546 | 42,716 | 47,622 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Jurgėnų biokuras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-03-18 | 2024-04-07 | 0.07 |
| 2024-02-19 | 2024-03-07 | 0.07 |
| 2023-10-25 | 2023-10-25 | 0.16 |
| 2023-10-17 | 2023-10-19 | 57.75 |
| 2023-09-18 | 2023-09-18 | 68.62 |
| 2023-08-17 | 2023-08-20 | 57.77 |
| 2023-07-24 | 2023-08-10 | 0.06 |
| 2023-05-16 | 2023-05-17 | 0.25 |
| 2023-05-02 | 2023-05-03 | 0.25 |
| 2023-04-27 | 2023-04-28 | 0.25 |
| 2023-04-25 | 2023-04-25 | 0.25 |
| 2023-04-18 | 2023-04-19 | 69.50 |
| 2023-03-16 | 2023-03-27 | 65.42 |
| 2023-02-17 | 2023-02-21 | 0.19 |
| 2023-01-23 | 2023-01-31 | 0.19 |
| 2022-11-17 | 2022-11-18 | 73.50 |
| 2022-10-28 | 2022-11-13 | 0.15 |
| 2022-10-18 | 2022-10-19 | 68.06 |
| 2022-09-16 | 2022-09-19 | 68.06 |
Jurgėnų biokuras - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Jurgenu biokuras, UAB (code 304178640) is a Private Limited Liability Company operating in the manufacture of other products of wood and articles of cork, straw and plaiting materials. In 2025, the company generated revenue of EUR 234.1K, down 11.1% year on year and 34.3% below the 2023 level of EUR 356.3K. Net profit improved to EUR 996 in 2025 from EUR 305 in 2024 and EUR 612 in 2023, although profitability remained very limited, with a 0.4% profit margin. Over the three-year period, revenue declined steadily, while earnings stayed close to break-even. The balance sheet showed total assets of EUR 261.8K in 2025, compared with EUR 248.2K in 2024 and EUR 254.7K in 2023. Equity increased slightly to EUR 92.2K, liabilities were EUR 111.2K, and the equity ratio stood at 35.2%. Key efficiency indicators were modest, with return on equity at 1.1%, return on assets at 0.4%, and asset turnover at 0.89x. Revenue per employee was EUR 58.5K.